NRT6008 Injection + Systematic chemotherapy Clinical Trials

1 actively recruiting trial

Also known as: Investigational Product + Systematic chemotherapy

Pipeline

Phase 1: 1

Top Sponsors

Chengdu New Radiomedicine Technology Co. LTD.1

Indications

Unresectable Pancreatic Cancer1
Cancer1

Other1 trial

Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.